Sio Capital Gains An Impressive 23.3% In 2018 As Biotech Shorts Pay Off: Here Are The Companies That They Are Betting Against

Sio Capital Management, the healthcare-focused long/short equity hedge fund achieved an outstanding outperformance for its partners in 2018.

Q4 hedge fund letters, conference, scoops etc

According to a copy of the firm's full-year letter, which has been reviewed by ValueWalk, Sio returned 23.3% net in 2018. These returns compare with returns of -4.4% for the S&P 500 Total Return Index, 1.0% for the MSCI World Healthcare Index, and -10.4% for the MSCI World Index.
If you’re looking for value stocks, and exclusive access to value-focused hedge fund managers, check out ValueWalk’s exclusive value newsletter, Hidden Value Stocks. Use code 15percent10 at checkout. Offer valid for next 10 subscribers or March 31, 2019 whichever comes first!


This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email and we will get back to you as quick as humanly possible

Saved Articles

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up today and get three months free

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 10/31/2019 or after next 25 20 subscribers take advantage whichever comes first – please do not share this discount with others